Erythropoietin for Management of Anemia Caused by Chemotherapy
Status:
Completed
Trial end date:
2017-12-07
Target enrollment:
Participant gender:
Summary
This is a phase Ⅱ study of erythropoietin for management of anemia caused by chemotherapy in
patients with Diffuse Large B-cell Lymphoma. The investigators want to investigate
hematopoietic response of darbepoietin alfa and the quality of life assessment of
increasement of hemoglobin.